LIVE
New today 802
Updated 864
New executives 501
Reported capital $ 17,173,813

ZEYNA CLINICAL RESEARCH, S.A.

CORPORATION (JOINT-STOCK COMPANY) ACTIVE No ranking1,014,823 total
RUC: 155781764-2-2026
Total views
65
Avg / month
5
Year peak
42
Current month -45.2 % vs Mar
23

Company information

Folio
155781764 Mercantil
Registration date
Validity
PERPETUAL
Status
ACTIVE
Last update
29/03/2026 (hace 3 días)

Highlights ZEYNA CLINICAL RESEARCH, S.A.

Currency
US DOLLAR
Share capital
10,000.00
RUC
155781764-2-2026

Executives ZEYNA CLINICAL RESEARCH, S.A. (7)

Name
Role
Links
View
  • Name ROMULA INOCENCIO VERGARA VERGARA Subscriber 1
    Role: Subscriber
    Links: 1
  • Name KRISTELL ANDREA VERGARA RIOS Subscriber 31
    Role: Subscriber
    Links: 31
  • Name PABLO SAMANIEGO PINTO Director / President 1
    Role: Director / President
    Links: 1
  • Name ROBERTO RODRIGUEZ CENTELLA Director / Secretary 4
    Role: Director / Secretary
    Links: 4
  • Name LUZ ANY AGUILAR ABREGO Director / Treasurer 1
    Role: Director / Treasurer
    Links: 1
  • Name IRVING IVAN LOPEZ VERGARA Resident Agent 9
    Role: Resident Agent
    Links: 9
  • Name LA REPRESENTACIÓN LEGALDE LA SOCIEDAD LA EJERCERÁ EL SECRETARIO. REPRESENTATIVE -
    Role: REPRESENTATIVE
    Links: -
*Links: number of companies where the executive appears with a role or relation.

Documents ZEYNA CLINICAL RESEARCH, S.A. (1)

Act
Date
View
  • Act Electronic Entry Nº 1 (Opening of Electronic Folio) Entry 114373/2026 (0) 22/03/2026
    Date: 22/03/2026

Entries / Precedence ZEYNA CLINICAL RESEARCH, S.A. (1)

Procedure / Document type
Year
View
  • Procedure / Doc. Incorporation of Company Capital, Single Fee, Qualification Rights 2026
    Year: 2026
About ZEYNA CLINICAL RESEARCH, S.A.: Summary of ZEYNA CLINICAL RESEARCH, S.A.: entity CORPORATION (JOINT-STOCK COMPANY), status VIGENTE. Address in Panamá. Registered since 22/03/2026. Estimated traffic: 65 total visits (peak 42). Position: no ranking available. See representatives, branches, documents and filings.